Related Experiment Videos
[Autoimmune hepatitis].
1Zavod za gastroenterologiju Interna klinika Klinicki bolnicki centar Zagreb Kispatićeva 12, 10000 Zagreb, Hrvatska.
Summary
Autoimmune hepatitis is a chronic liver inflammation diagnosed by specific autoantibodies and histologic findings. Treatment typically involves corticosteroids and azathioprine, with liver transplantation as an option for severe cases.
Area of Science:
- Hepatology
- Immunology
- Internal Medicine
Context:
- Autoimmune hepatitis (AIH) is a persistent liver inflammation of unknown etiology.
- Diagnosis relies on histological evidence of periportal hepatitis, autoantibodies, and hypergammaglobulinemia.
- International consensus now uses the term AIH, replacing previous designations.
Purpose:
- To outline the classification, diagnosis, and management of autoimmune hepatitis.
- To describe the three distinct immunoserologic types of AIH.
- To highlight diagnostic challenges and treatment strategies.
Summary:
- AIH presents with hepatocellular inflammation, characterized by periportal hepatitis, autoantibodies (ANA, SMA, anti-LKM1, anti-SLA), and elevated immunoglobulins.
- Type 1 AIH (ANA/SMA positive) predominantly affects women, while Type 2 (anti-LKM1 positive) is more common in children.
- Type 3 AIH (anti-SLA positive) is also recognized, with diagnosis requiring exclusion of other liver diseases.
- Corticosteroids are the primary treatment, often combined with azathioprine for steroid-sparing effects and sustained remission.
- Liver transplantation is reserved for patients with decompensated liver disease.
Impact:
- Provides a comprehensive overview of autoimmune hepatitis for clinicians and researchers.
- Clarifies the diagnostic criteria and subtypes of AIH.
- Informs treatment decisions and patient management strategies for autoimmune liver disease.